Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

1 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	203-209
Number of pages	7
Journal	Clinical and Experimental Gastroenterology
Volume	10
DOIs	https://doi.org/10.2147/ceg.s135526
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{70cbefb5b0194c99a0fb39345bb053e6,

title = "Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B",

author = "Juan Li and Auke Verhaar and Qiuwei Pan and {de Knegt}, Rob and Maikel Peppelenbosch",

year = "2017",

doi = "10.2147/ceg.s135526",

language = "Undefined/Unknown",

volume = "10",

pages = "203--209",

journal = "Clinical and Experimental Gastroenterology",

issn = "1178-7023",

publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B

AU - Li, Juan

AU - Verhaar, Auke

AU - Pan, Qiuwei

AU - de Knegt, Rob

AU - Peppelenbosch, Maikel

PY - 2017

Y1 - 2017

U2 - 10.2147/ceg.s135526

DO - 10.2147/ceg.s135526

M3 - Article

VL - 10

SP - 203

EP - 209

JO - Clinical and Experimental Gastroenterology

JF - Clinical and Experimental Gastroenterology

SN - 1178-7023

ER -